The DANCR/miR-145-5p/CD133 Axis Drives Osteosarcoma Stemness and Progression: Implications for Tumor Biology and Therapeutic Innovation
Cells · 03.07.2026 · 15 (13) · 1215
DOI: 10.3390/cells15131215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 03.07.2026. Verfasst von Wei-Ting Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Integrated TCM & Western Medicine Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 4300…. Hauptthemen laut MEDLINE: Osteosarcoma, MicroRNAs, AC133 Antigen, RNA, Long Noncoding. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science Foundation of China.
Abstract (Originalsprache)
Characterized by its highly aggressive behavior and propensity for metastasis, osteosarcoma remains a formidable clinical challenge with restricted treatment modalities. Cancer stem-like cells (CSCs) are widely recognized as central orchestrators of oncogenic progression and therapeutic intractability; however, the precise epigenetic regulations governing these processes are yet to be fully elucidated. Here, we investigated the role of the long non-coding RNA DANCR in regulating osteosarcoma stemness. DANCR expression was significantly upregulated in human osteosarcoma tissues and positively correlated with the stemness markers CD133, SOX2, and CD90. Functional assays demonstrated that DANCR overexpression enhanced stem-like properties, including an enriched CD133+/CD44+ cellular fraction and enhanced spheroid-forming capacity, concurrently accelerating in vitro cellular proliferation, migration, and invasive potential. In a xenograft mouse model, DANCR upregulation promoted in vivo tumor growth and lung metastasis. Mechanistically, dual-luciferase reporter assays and RNA immunoprecipitation (RIP) revealed that DANCR acts as a competing endogenous RNA (ceRNA) by sponging miR-145-5p, thereby facilitating the de-repression of CD133 and contributing to Akt/mTOR signaling activation. In addition, DANCR/miR-145-5p modulation was associated with changes in autophagy-associated markers. Collectively, these findings identify the DANCR/miR-145-5p/CD133 axis as a regulator of osteosarcoma stemness and progression, providing new insights into tumor biology and highlighting a potential molecular target for therapeutic investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Integrated TCM & Western Medicine Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.
Förderung
- National Natural Science Foundation of China
- National Science Foundation of China
Zitieren
APA
Cheng, W. T., Yang, C. H., Qi, J., Ye, Y. P., Bao, X., Mei, Q., Guo, J. C., & Xu, K. (2026). The DANCR/miR-145-5p/CD133 Axis Drives Osteosarcoma Stemness and Progression: Implications for Tumor Biology and Therapeutic Innovation. Cells, 15(13), 1215. https://doi.org/10.3390/cells15131215
Vancouver
Cheng WT, Yang CH, Qi J, Ye YP, Bao X, Mei Q, et al. The DANCR/miR-145-5p/CD133 Axis Drives Osteosarcoma Stemness and Progression: Implications for Tumor Biology and Therapeutic Innovation. Cells. 2026;15(13):1215. doi:10.3390/cells15131215
BibTeX
@article{Cheng2026,
author = {Cheng, Wei-Ting and Yang, Cai-Hong and Qi, Jun and Ye, Ya-Ping and Bao, Xing and Mei, Qi and Guo, Jia-Chao and Xu, Kai},
title = {The DANCR/miR-145-5p/CD133 Axis Drives Osteosarcoma Stemness and Progression: Implications for Tumor Biology and Therapeutic Innovation},
journal = {Cells},
year = {2026},
volume = {15},
number = {13},
pages = {1215},
doi = {10.3390/cells15131215}
}
EUVIMED